Clinical Features
Opioid Prescribing Updates
Opioid Prescribing Updates from the Updated CDC Opioid Prescribing Guidelines A 45-year-old gentleman was admitted to hospital with a fractured tibial plateau following a road traffic collision. He…
News
Page 42
Clinical Features
Establishing a National Cancer Mission Hub
The NCCP Collaborates with the All-Island Cancer Research Institute (AICRI) to establish a National Cancer Mission Hub in Ireland Establishing of Cancer Mission Hubs: Networks and Synergies (ECHoS)…
Clinical Features
Empowering Lung Cancer Care: RNA Therapeutics Expand Treatment Frontiers
Challenges in Lung Cancer Treatment Lung cancer stands as the leading cause of cancer-related deaths, both in Ireland and worldwide, making it a prominent contributor to the global…
Clinical Features
Extramedullary Multiple Myeloma
Extramedullary Multiple Myeloma Introduction: Multiple myeloma (MM) is the second most common blood cancer worldwide and is characterised by clonal proliferation of malignant plasma cells within the bone…
Latest News
safefood offers practical tips for a healthy heart ahead of World Heart Day
With Irish Heart month being celebrated in September and World Heart Day taking place on the 29th of this month, it’s time to remind ourselves that our hearts…
Clinical Features
Waking up to Pain
Chronic Pain Ireland launches ‘Waking up to Pain’ campaign for Pain Awareness Month Written by Martina Phelan, Chair, Chronic Pain Ireland The World Health Assembly (WHA), a subsection…
Professional 100
Enter the Professional 100 2023
Hospital Professional News’ annual Professional Top 100 celebrates hospital professionals who are driving secondary care excellence across Ireland. WHO CAN ENTER? Consultants, Specialists, Hospital Pharmacists, Industry & Regulatory…
Latest News
Health Services Research & Pharmacy Practice (HSRPP) Conference 2024
We are delighted to announce that next year’s Health Services Research & Pharmacy Practice (HSRPP) conference will take place in University College Cork on 25 – 26 April 2024. This will be the 30th…
Product News
Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations
Approval for AKEEGA® is based on results from the Phase 3 MAGNITUDE study, a prospectively designed precision medicine study that includes the largest cohort to date of BRCA1/2-positive patients with untreated metastatic castration-resistant…
Product News
Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel
Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets. Full prescribing information is available on request or alternatively please go…
You’re all caught up.